PDCD1 and familial pancreatic carcinoma: Similarly, a study in advanced pancreatic cancer patients evaluated the differences in efficacy of chemotherapy (n = 36) vs. chemotherapy in combination with PD-1/PD-L1 blockade (n = 22) [31].